VeriMomyeast beta-glucan est-il sûr pendant la grossesse ?
CIR (Cosmetic Ingredient Review) evaluated Yeast Beta‑Glucan (and related yeast‑derived ingredients) and concluded topical uses in cosmetics are safe as used; the CIR toxicokinetic data showed no measurable systemic absorption after short‑term oral exposure and dermal studies showed low systemic toxicity at high doses, and there is no harmonised ECHA CLP reproductive classification for yeast beta‑glucan. No credible animal or human evidence indicates reproductive teratogenicity or H360/H361‑level hazard. (CIR safety assessment; ADME/tox studies; no harmonised CLP).
Pregnancy-safe products containing yeast beta-glucan
Related ingredients
Frequently asked questions
- yeast beta-glucan est-il sûr pendant la grossesse ?
- CIR (Cosmetic Ingredient Review) evaluated Yeast Beta‑Glucan (and related yeast‑derived ingredients) and concluded topical uses in cosmetics are safe as used; the CIR toxicokinetic data showed no measurable systemic absorption after short‑term oral exposure and dermal studies showed low systemic toxicity at high doses, and there is no harmonised ECHA CLP reproductive classification for yeast beta‑glucan. No credible animal or human evidence indicates reproductive teratogenicity or H360/H361‑level hazard. (CIR safety assessment; ADME/tox studies; no harmonised CLP).
- yeast beta-glucan est-il sûr pendant l'allaitement ?
- No evidence of reproductive or lactation hazard in authoritative safety reviews; topical cosmetic use is expected to give negligible systemic exposure per CIR data, so transfer to breast milk is unlikely. No clinical or animal data indicate breast‑feeding specific hazard. (CIR toxicokinetic/tox data; PubMed literature search found no reproductive/lactation toxicity signal).
- yeast beta-glucan est-il sûr pour la peau de bébé ?
- Hazard and mechanism: authoritative review (CIR) and available toxicology do not indicate reproductive or developmental toxicity for yeast beta‑glucan. Exposure: CIR dermal/use data and ADME indicate negligible systemic absorption for adults; because infant skin barrier is immature, apply the scoring rule (+1) to exposure for 0–3 yr infants, giving e=1 (low but measurable relative to adult). There are no infant‑specific toxicity signals to increase h or m. (CIR + general ADME/tox literature).
- Comment VeriMom évalue-t-il yeast beta-glucan ?
- VeriMom évalue yeast beta-glucan à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à yeast beta-glucan pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à yeast beta-glucan basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.